Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Mochida ReFeel for Digital Nerve Injuries

NCT: NCT07524465 · NOT_YET_RECRUITING

NCT IDNCT07524465
StatusNOT_YET_RECRUITING
Start Date2026-05-01
Completion2028-12-31

Brief Summary

This is an Investigator Led single-center, Prospective and Observational, Clinical Research Project. The specific aim of this study is to test/observe the safety and effectiveness of the ReFeel Device for Digital nerve injury in improving recovery time and outcomes. The primary objective of this study is to monitor clinical and surgical procedural outcomes for the use of ReFeel device.

Frequently Asked Questions

What is Mochida ReFeel for Digital Nerve Injuries?

Mochida ReFeel for Digital Nerve Injuries is a clinical trial registered under NCT07524465. Current status: NOT_YET_RECRUITING.

What is the status of NCT07524465?

The current status of NCT07524465 (Mochida ReFeel for Digital Nerve Injuries) is: NOT_YET_RECRUITING.

When did Mochida ReFeel for Digital Nerve Injuries start?

Mochida ReFeel for Digital Nerve Injuries started on 2026-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.